| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Biogen Inc. (BIIB) has 15 insiders with recent SEC Form 4 filings, including 7 buys and 6 sells. BIIB is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 31.0K | $6.35M | - | |
| Dir | 24.3K | $4.99M | - | |
| Dir | 13.7K | $2.81M | - | |
| Dir | 9.8K | $2.00M | - | |
| Dir | 8.9K | $1.82M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 1, 2019 | Denner Alexander J66 | Director | Buy | 62,800 | $327.59 | $20,572,406.38 | +4.3% | |
| Sep 26, 2018 | Ehlers Michael D | EVP, Research And Development | Sell | 1,000 | $350.00 | $350,000.00 | -18.9% | |
| Apr 25, 2018 | Denner Alexander J66 | Director | Buy | 48,000 | $269.91 | $12,955,680.00 | +11.6% | |
| Feb 27, 2018 | Sandrock Alfred67 | EVP, Chief Medical Officer | Sell | 259 | $290.83 | $75,324.97 | -3.8% | |
| Feb 23, 2018 | Sandrock Alfred67 | EVP, Chief Medical Officer | Sale+OE | 908 | $293.44 | $266,443.52 | -12.2% | |
| Feb 20, 2018 | Sandrock Alfred67 | EVP, Chief Medical Officer | Sell | 743 | $292.00 | $216,956.00 | -10.2% | |
| Feb 15, 2018 | Sandrock Alfred67 | EVP, Chief Medical Officer | Sell | 1,294 | $298.85 | $386,711.90 | -15.1% | |
| Jan 9, 2018 | Pangia Robert W | Director | Sale+OE | 5,832 | $329.65 | $1,922,518.80 | -24.8% | |
| Dec 29, 2017 | Vounatsos Michel | Chief Executive Officer | Buy | 780 | $320.55 | $250,029.00 | +19.0% | |
| Nov 29, 2017 | Denner Alexander J66 | Director | Buy | 30,000 | $317.36 | $9,520,800.00 | +3.8% |